Interestingly, a recent research aiming to discuss the roles of CKI on tumor immunity reveals that CKI alleviates the immunosuppressive effects of tumor-associated macrophages and afterwards relieves the its immune suppression on CD8+ T cells, which eventually improves the effects of low-dose sorafenib and reduces the adverse effects of chemotherapy (24). The gene discussed is CD8A; the disease is neoplasm.